ZA922952B - 2-aminopyrimidine-4-carboxyamide derivatives,their preparation and their application in therapy - Google Patents

2-aminopyrimidine-4-carboxyamide derivatives,their preparation and their application in therapy

Info

Publication number
ZA922952B
ZA922952B ZA922952A ZA922952A ZA922952B ZA 922952 B ZA922952 B ZA 922952B ZA 922952 A ZA922952 A ZA 922952A ZA 922952 A ZA922952 A ZA 922952A ZA 922952 B ZA922952 B ZA 922952B
Authority
ZA
South Africa
Prior art keywords
aminopyrimidine
therapy
preparation
application
carboxyamide derivatives
Prior art date
Application number
ZA922952A
Other languages
English (en)
Inventor
Pascal George
George Pascal
Philippe Manoury
Manoury Philippe
Michel Mangane
Mangane Michel
Jean-Pierre Merly
Merly Jean-Pierre
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA922952B publication Critical patent/ZA922952B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA922952A 1991-04-24 1992-04-23 2-aminopyrimidine-4-carboxyamide derivatives,their preparation and their application in therapy ZA922952B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105043A FR2675799B1 (fr) 1991-04-24 1991-04-24 Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
ZA922952B true ZA922952B (en) 1993-01-27

Family

ID=9412198

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922952A ZA922952B (en) 1991-04-24 1992-04-23 2-aminopyrimidine-4-carboxyamide derivatives,their preparation and their application in therapy

Country Status (18)

Country Link
US (1) US5229392A (xx)
EP (1) EP0511072A1 (xx)
JP (1) JPH05117243A (xx)
KR (1) KR920019760A (xx)
CN (1) CN1066066A (xx)
AU (1) AU1507992A (xx)
CA (1) CA2066960A1 (xx)
CS (1) CS124492A3 (xx)
FI (1) FI921814A (xx)
FR (1) FR2675799B1 (xx)
HU (1) HUT61002A (xx)
IE (1) IE921319A1 (xx)
IL (1) IL101617A0 (xx)
MX (1) MX9201866A (xx)
NO (1) NO921563L (xx)
NZ (1) NZ242464A (xx)
PL (1) PL294309A1 (xx)
ZA (1) ZA922952B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2699171B1 (fr) * 1992-12-14 1995-02-03 Synthelabo Dérivés de 2-amino-N[[[4-aminocarbonyl) pyrimidin-2-yl]amino]alkyl]pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
ATE123025T1 (de) * 1992-07-03 1995-06-15 Synthelabo 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
FR2697253B1 (fr) * 1992-10-22 1994-12-02 Synthelabo Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
ES2074946B1 (es) * 1993-07-19 1996-06-16 Ferrer Int Nuevos compuestos derivados de la 1,2-etanodiamina-n,n,n',n'-tetrasustituida.
CN1066718C (zh) * 1993-08-19 2001-06-06 詹森药业有限公司 取代的芳氧基烷基二胺及其制备方法和用途
FR2724383B1 (fr) * 1994-09-13 1996-10-18 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
EP1075486A1 (en) * 1998-05-06 2001-02-14 Duke University Method of treating bladder and lower urinary tract syndromes
US10975238B2 (en) * 2016-10-25 2021-04-13 Arizona Board Of Regents On Behalf Of Arizona State University Solvent-less ionic liquid epoxy resin
CN113646355A (zh) 2019-02-18 2021-11-12 亚利桑那州立大学董事会 无溶剂离子液体环氧树脂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191845B (it) * 1986-01-20 1988-03-23 Dompe Farmaceutici Spa Alchiloli derivati farmacologicamente attivi

Also Published As

Publication number Publication date
CS124492A3 (en) 1992-11-18
IL101617A0 (en) 1992-12-30
FI921814A0 (fi) 1992-04-23
NO921563D0 (no) 1992-04-23
US5229392A (en) 1993-07-20
FR2675799B1 (fr) 1993-12-24
FI921814A (fi) 1992-10-25
KR920019760A (ko) 1992-11-19
JPH05117243A (ja) 1993-05-14
HUT61002A (en) 1992-11-30
CA2066960A1 (en) 1992-10-25
CN1066066A (zh) 1992-11-11
EP0511072A1 (fr) 1992-10-28
MX9201866A (es) 1992-10-01
NZ242464A (en) 1993-05-26
HU9201358D0 (en) 1992-07-28
AU1507992A (en) 1992-10-29
NO921563L (no) 1992-10-26
IE921319A1 (en) 1992-11-04
FR2675799A1 (fr) 1992-10-30
PL294309A1 (en) 1992-11-02

Similar Documents

Publication Publication Date Title
IL101865A0 (en) Thiopyranopyrrole derivatives and their preparation
FI944600A (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
IL99612A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their use in therapy
IL87089A0 (en) N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
ZA926189B (en) Beta-Phenylisoserine derivatives and their preparation and use.
AU2557892A (en) New beta -carbolin derivatives, their preparation and their use in drugs
IL107133A0 (en) Piperidine derivatives,their preparation and their application in therapy
ZA922952B (en) 2-aminopyrimidine-4-carboxyamide derivatives,their preparation and their application in therapy
ZA862708B (en) Nitrofuran derivatives,the preparation thereof and their application in therapy
HU9300595D0 (en) New hetero-aryl-oxi-beta-carbolines, their production and application in medicament
IL90000A0 (en) Benzothiazepin-4-one derivatives,their preparation and their application in therapy
ZA898480B (en) Phenyloxypropanolamine derivatives,their preparation and their application in therapeutics
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
ZA904290B (en) 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives,their preparation and their application in therapy
AU1858692A (en) 2-piperidinylpyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics
AU5975094A (en) 1,2,4-triazinone derivatives and their use in therapy
GB2253851B (en) Pyridine derivatives,their preparation and pharmaceutical use
ZA907628B (en) 3-isoxazolone derivatives,their preparation and their therapeutic uses
EP0352083A3 (en) Alkenyltetrazole derivatives, their preparation and use
AU5233893A (en) 3-(6-Quinolylmethyl)-4H-imidazol-4-one derivatives, their preparation and their application in therapy
GB9115197D0 (en) Furocoumarin derivatives,their preparation and their use in therapy
ZA921060B (en) Polyhydroxycyclopentane derivatives,their preparation and their therapeutic use
ZA921298B (en) 1-biphenylimidazole derivatives,their preparation and their therapeutic use
GB9214293D0 (en) Furocoumarin derivatives,their preparation and their use in therapy